Untitled
Untitled
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Recommendations regarding splenectomy in hereditary hemolytic anemias | Haematologica
Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Haematologica, Volume 105, Issue 7 by Haematologica - Issuu
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Haematologica, Volume 105, Issue 10 by Haematologica - Issuu
Untitled
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Untitled
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png "PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model")
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients | Haematologica
PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
